Imagine that a researcher has dissected out a single muscle bundle from a triceps muscle biopsy. She sections this bundle and stains it for a variety of muscle-associated proteins. After staining, when the researcher zooms in on a sarcomere, she notices that a certain protein always dots the periphery along the length of the thin filaments. This protein is most likely:

Explanation:

This protein is most likely:  Tropomyosin.

Sacromere is the structural unit of myofibrils i.e. the fibres of the muscles.

Tropomyosin is the muscle protein that function in contraction of muscle filaments.They are arranged laterally along the myofilament. When the researcher is observing the sacromere, she is observing the muscle fibre.  So, the protein that lines the periphery along the thin filament is more likely to be tropomysin.

"1. it should be, it has been for about 20 years, and it's really not much different in the end than breeding animals to have particular traits. there are always concerns about genetically engineered animals/plants affecting the environment in unexpected negative ways, but i can't think of an example where the fears didn't turn out to be baseless.  

first, as you point out, it would be a great advance in pharmacology, to be able to tailor drugs and their doses to me. the pros involve better medical treatment. the cons involve privacy issues like insurance companies denying coverage to people with genetic risk factors. looking at dna markers wouldn't affect the frequency of genetic diseases, but it would allow detection of them earlier. and ok, actually i suppose that if people used this information to avoid having children with genetic diseases, some might decrease in frequency."

idk im sorry.